AVXL

AVXL Other Income/Expenses (Net)

$6.61MTTM · USD

Period ending:

AVXL FY Other Income/Expenses (Net)USD
AVXL FY Other Income/Expenses (Net)2004-09-30: $0.002005-09-30: $125.002006-09-30: $59.002007-09-30: $1.24K2008-09-30: -$9.77K2009-09-30: -$707.63K2010-09-30: -$2.85M2011-09-30: -$1.04M2012-09-30: -$3.84M2013-09-30: -$1.51M2014-09-30: $232.70K2015-09-30: $70.55K2016-09-30: $164.16K2017-09-30: $2.05M2018-09-30: $1.58M2019-09-30: $2.54M2020-09-30: $455.40K2021-09-30: $4.36M2022-09-30: $3.37M2023-09-30: $8.26M2024-09-30: $9.88M2025-09-30: $5.03M$9.88M-$3.84M
2004-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AVXL other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 22 observations from Sep 30, 2004 to Sep 30, 2025.

Anavex Life Sciences Corp Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
5,031,000
9,875,000
8,258,000
3,366,000
4,361,000
455,401
2,539,060
1,579,724
2,050,523
164,162
70,554
232,697
-1,511,338
-3,841,873
-1,036,319
-2,849,810
-707,626
-9,772
1,237
59
125
0

Compare other income/expenses (net)

All AVXL financial metrics · AVXL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.